US life sciences sector leader DTTL Global life sciences sector leader
Greg leads the DTTL Global and US Life Sciences practices for Deloitte.
In his role with Deloitte’s US member firm, he leads the life sciences sector practices for consulting, audit, tax, and financial advisory services. Greg has more than 25 years of experience helping clients in the life sciences, process manufacturing, consumer, and government sectors. In his role consulting to clients, his career has spanned such topics as technology strategy, integration solution development, and implementation of emerging and disruptive technology.
His clients have included multinational pharmaceutical, biotechnology, and chemical manufacturing organizations where he has successfully led consulting services in support of regulatory, clinical, commercialization, and manufacturing operations.
Prior to his consulting career Greg held positions at a government research lab, where he led teams in the design and development of life support devices; and was a lecturer at the University of Pennsylvania.
Health Care Current: March 22, 2016 Is medical innovation ready for the evolution of value-based care?
2016 Life Sciences Industry Outlook
What factors are likely to shape the life sciences industry in the coming year and beyond? Read Deloitte's 2016 Life Sciences Outlook.
Improving medication adherence
Increasing medication adherence is critical. Explore new ideas and insights for designing adherence-related patient interventions.
Life at Deloitte
People make Deloitte one of the best places to work. What’s great about the people? That’s an easy answer. They are exceptional. Each person is unique and valued for that, among the best and brightest in the business, and takes pride in his or her achievements and the success of others.